+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurotransmitter"

Cholinergic Drugs Market Report 2025 - Product Thumbnail Image

Cholinergic Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Anticholinergic Drugs Market Report 2025 - Product Thumbnail Image

Anticholinergic Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Neurological Disorder Drugs Market Report 2025 - Product Thumbnail Image

Neurological Disorder Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Muscarinic Acetylcholine Receptor Market Report 2025 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Huntington's Disease Treatment Global Market Report 2025 - Product Thumbnail Image

Huntington's Disease Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Antiepileptic Drugs Global Market Report 2025 - Product Thumbnail Image

Antiepileptic Drugs Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Phenobarbital Global Market Report 2025 - Product Thumbnail Image

Phenobarbital Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Dementia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dementia Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 286 Pages
  • Global
From
From
Dystonia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dystonia Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 369 Pages
  • Global
From
Citicoline - Global Strategic Business Report - Product Thumbnail Image

Citicoline - Global Strategic Business Report

  • Report
  • August 2025
  • 461 Pages
  • Global
From
Restless Legs Syndrome - Global Strategic Business Report - Product Thumbnail Image

Restless Legs Syndrome - Global Strategic Business Report

  • Report
  • August 2025
  • 290 Pages
  • Global
From
Epilepsy Drugs - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 276 Pages
  • Global
From
Anticholinergic Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticholinergic Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 93 Pages
  • Global
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 382 Pages
  • Global
From
Botulinum Toxin - Global Strategic Business Report - Product Thumbnail Image

Botulinum Toxin - Global Strategic Business Report

  • Report
  • August 2025
  • 353 Pages
  • Global
From
Fragile X Syndrome (FXS) Treatment Global Market Report 2025 - Product Thumbnail Image

Fragile X Syndrome (FXS) Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Myotonic Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Myotonic Dystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Epilepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Epilepsy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Loading Indicator

The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain. The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more